» Articles » PMID: 30849372

Characterizing Mutational Signatures in Human Cancer Cell Lines Reveals Episodic APOBEC Mutagenesis

Abstract

Multiple signatures of somatic mutations have been identified in cancer genomes. Exome sequences of 1,001 human cancer cell lines and 577 xenografts revealed most common mutational signatures, indicating past activity of the underlying processes, usually in appropriate cancer types. To investigate ongoing patterns of mutational-signature generation, cell lines were cultured for extended periods and subsequently DNA sequenced. Signatures of discontinued exposures, including tobacco smoke and ultraviolet light, were not generated in vitro. Signatures of normal and defective DNA repair and replication continued to be generated at roughly stable mutation rates. Signatures of APOBEC cytidine deaminase DNA-editing exhibited substantial fluctuations in mutation rate over time with episodic bursts of mutations. The initiating factors for the bursts are unclear, although retrotransposon mobilization may contribute. The examined cell lines constitute a resource of live experimental models of mutational processes, which potentially retain patterns of activity and regulation operative in primary human cancers.

Citing Articles

Inferring active mutational processes in cancer using single cell sequencing and evolutionary constraints.

Satas G, Myers M, McPherson A, Shah S bioRxiv. 2025; .

PMID: 40060559 PMC: 11888314. DOI: 10.1101/2025.02.24.639589.


Refined variant calling pipeline on RNA-seq data of breast cancer cell lines without matched-normal samples.

Eberth S, Koblitz J, Steenpass L, Pommerenke C BMC Res Notes. 2025; 18(1):67.

PMID: 39955561 PMC: 11829467. DOI: 10.1186/s13104-025-07140-3.


APOBEC-1 cofactors regulate APOBEC3-induced mutations in hepatitis B virus.

Chen Z, Eggerman T, Bocharov A, Baranova I, Vishnyakova T, Patterson A J Virol. 2025; 99(2):e0187924.

PMID: 39868801 PMC: 11853063. DOI: 10.1128/jvi.01879-24.


VACCIMEL, an allogeneic melanoma vaccine, efficiently triggers T cell immune responses against neoantigens and alloantigens, as well as against tumor-associated antigens.

Carri I, Schwab E, Trivino J, von Euw E, Nielsen M, Mordoh J Front Immunol. 2025; 15():1496204.

PMID: 39840067 PMC: 11747570. DOI: 10.3389/fimmu.2024.1496204.


Prolonged persistence of mutagenic DNA lesions in somatic cells.

Spencer Chapman M, Mitchell E, Yoshida K, Williams N, Fabre M, Ranzoni A Nature. 2025; 638(8051):729-738.

PMID: 39814886 PMC: 11839459. DOI: 10.1038/s41586-024-08423-8.


References
1.
Abecasis G, Auton A, Brooks L, DePristo M, Durbin R, Handsaker R . An integrated map of genetic variation from 1,092 human genomes. Nature. 2012; 491(7422):56-65. PMC: 3498066. DOI: 10.1038/nature11632. View

2.
Chan K, Sterling J, Roberts S, Bhagwat A, Resnick M, Gordenin D . Base damage within single-strand DNA underlies in vivo hypermutability induced by a ubiquitous environmental agent. PLoS Genet. 2012; 8(12):e1003149. PMC: 3521656. DOI: 10.1371/journal.pgen.1003149. View

3.
Roberts S, Sterling J, Thompson C, Harris S, Mav D, Shah R . Clustered mutations in yeast and in human cancers can arise from damaged long single-strand DNA regions. Mol Cell. 2012; 46(4):424-35. PMC: 3361558. DOI: 10.1016/j.molcel.2012.03.030. View

4.
Nik-Zainal S, Davies H, Staaf J, Ramakrishna M, Glodzik D, Zou X . Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature. 2016; 534(7605):47-54. PMC: 4910866. DOI: 10.1038/nature17676. View

5.
Haradhvala N, Kim J, Maruvka Y, Polak P, Rosebrock D, Livitz D . Distinct mutational signatures characterize concurrent loss of polymerase proofreading and mismatch repair. Nat Commun. 2018; 9(1):1746. PMC: 5931517. DOI: 10.1038/s41467-018-04002-4. View